Literature DB >> 19398586

Targeted knock-in mice expressing mutations of CD28 reveal an essential pathway for costimulation.

Lindzy F Dodson1, Jonathan S Boomer, Christine M Deppong, Dulari D Shah, Julia Sim, Traci L Bricker, John H Russell, Jonathan M Green.   

Abstract

Despite extensive study, the role of phosphatidylinositol 3-kinase (PI3-kinase) activation in CD28 function has been highly contentious. To definitively address this question, we generated knock-in mice expressing mutations in two critical domains of the cytoplasmic tail of CD28. Mutation of the proximal tyrosine motif interrupted PI3-kinase binding and prevented CD28-dependent phosphorylation of protein kinase B (PKB)/Akt; however, there was no detectable effect on interleukin-2 (IL-2) secretion, expression of Bcl-X(L), or on T-cell function in vivo. Furthermore, we demonstrate that signaling initiated by the C-terminal proline motif is directly responsible for tyrosine phosphorylation of phosphoinosotide-dependent kinase 1, protein kinase C theta, and glycogen synthase kinase 3beta, as well as contributing to threonine phosphorylation of PKB. T cells mutated in this domain were profoundly impaired in IL-2 secretion, and the mice had marked impairment of humoral responses as well as less severe disease manifestations in experimental allergic encephalomyelitis. These data demonstrate that the distal proline motif initiates a critical nonredundant signaling pathway, whereas direct activation of PI3-kinase by the proximal tyrosine motif of CD28 is not required for normal T-cell function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19398586      PMCID: PMC2698768          DOI: 10.1128/MCB.01869-08

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  58 in total

Review 1.  Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research.

Authors:  Ralf Gold; Christopher Linington; Hans Lassmann
Journal:  Brain       Date:  2006-04-21       Impact factor: 13.501

2.  Regulation of Akt/PKB Ser473 phosphorylation.

Authors:  Jose R Bayascas; Dario R Alessi
Journal:  Mol Cell       Date:  2005-04-15       Impact factor: 17.970

3.  Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition.

Authors:  Mark C Genovese; Jean-Claude Becker; Michael Schiff; Michael Luggen; Yvonne Sherrer; Joel Kremer; Charles Birbara; Jane Box; Kannan Natarajan; Isaac Nuamah; Tracy Li; Richard Aranda; David T Hagerty; Maxime Dougados
Journal:  N Engl J Med       Date:  2005-09-15       Impact factor: 91.245

4.  TcR and TcR-CD28 engagement of protein kinase B (PKB/AKT) and glycogen synthase kinase-3 (GSK-3) operates independently of guanine nucleotide exchange factor VAV-1.

Authors:  Joanne E Wood; Helga Schneider; Christopher E Rudd
Journal:  J Biol Chem       Date:  2006-08-11       Impact factor: 5.157

5.  Protein kinase C-theta-mediated signals enhance CD4+ T cell survival by up-regulating Bcl-xL.

Authors:  Santhakumar Manicassamy; Sonal Gupta; Zhaofeng Huang; Zuoming Sun
Journal:  J Immunol       Date:  2006-06-01       Impact factor: 5.422

6.  Cytokine-stimulated phosphorylation of GSK-3 is primarily dependent upon PKCs, not PKB.

Authors:  Dino Vilimek; Vincent Duronio
Journal:  Biochem Cell Biol       Date:  2006-02       Impact factor: 3.626

Review 7.  Protein kinase C theta (PKCtheta): a key player in T cell life and death.

Authors:  Keitaro Hayashi; Amnon Altman
Journal:  Pharmacol Res       Date:  2007-05-01       Impact factor: 7.658

8.  Negative regulation of T cell proliferation and interleukin 2 production by the serine threonine kinase GSK-3.

Authors:  T Ohteki; M Parsons; A Zakarian; R G Jones; L T Nguyen; J R Woodgett; P S Ohashi
Journal:  J Exp Med       Date:  2000-07-03       Impact factor: 14.307

9.  Phosphoinositide-dependent kinase 1 targets protein kinase A in a pathway that regulates interleukin 4.

Authors:  Ajay Nirula; Mary Ho; Hyewon Phee; Jeroen Roose; Arthur Weiss
Journal:  J Exp Med       Date:  2006-06-19       Impact factor: 14.307

10.  A dose-dependent requirement for the proline motif of CD28 in cellular and humoral immunity revealed by a targeted knockin mutant.

Authors:  Lindzy D Friend; Dulari D Shah; Christine Deppong; Joseph Lin; Traci L Bricker; Twyla I Juehne; Christine M Rose; Jonathan M Green
Journal:  J Exp Med       Date:  2006-08-14       Impact factor: 14.307

View more
  39 in total

Review 1.  An enigmatic tail of CD28 signaling.

Authors:  Jonathan S Boomer; Jonathan M Green
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-09       Impact factor: 10.005

2.  In the absence of its cytosolic domain, the CD28 molecule still contributes to T cell activation.

Authors:  Stéphanie O Morin; Valentin Giroux; Cédric Favre; Yassina Bechah; Nathalie Auphan-Anezin; Romain Roncagalli; Jean-Louis Mège; Daniel Olive; Marie Malissen; Jacques A Nunès
Journal:  Cell Mol Life Sci       Date:  2015-03-01       Impact factor: 9.261

3.  CD28 co-signaling in the adaptive immune response.

Authors:  Pavel Riha; Christopher E Rudd
Journal:  Self Nonself       Date:  2010-07-12

4.  Cutting edge: A double-mutant knockin of the CD28 YMNM and PYAP motifs reveals a critical role for the YMNM motif in regulation of T cell proliferation and Bcl-xL expression.

Authors:  Jonathan S Boomer; Christine M Deppong; Dulari D Shah; Traci L Bricker; Jonathan M Green
Journal:  J Immunol       Date:  2014-03-17       Impact factor: 5.422

Review 5.  Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/ B7 family.

Authors:  Hélène Bour-Jordan; Jonathan H Esensten; Marc Martinez-Llordella; Cristina Penaranda; Melanie Stumpf; Jeffrey A Bluestone
Journal:  Immunol Rev       Date:  2011-05       Impact factor: 12.988

6.  Combinatorial signals from CD28 differentially regulate human immunodeficiency virus transcription in T cells.

Authors:  Malini Natarajan; Avery August; Andrew J Henderson
Journal:  J Biol Chem       Date:  2010-04-05       Impact factor: 5.157

7.  T Cell Reprogramming Against Cancer.

Authors:  Samuel G Katz; Peter M Rabinovich
Journal:  Methods Mol Biol       Date:  2020

Review 8.  T cell costimulation, checkpoint inhibitors and anti-tumor therapy.

Authors:  Dipankar Nandi; Sanmoy Pathak; Taru Verma; Madhulika Singh; Avik Chattopadhyay; Samriddhi Thakur; Abinaya Raghavan; Abhijeet Gokhroo
Journal:  J Biosci       Date:  2020       Impact factor: 1.826

Review 9.  CD28 Costimulation: From Mechanism to Therapy.

Authors:  Jonathan H Esensten; Ynes A Helou; Gaurav Chopra; Arthur Weiss; Jeffrey A Bluestone
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

10.  Binding of the cytoplasmic domain of CD28 to the plasma membrane inhibits Lck recruitment and signaling.

Authors:  Jessica Dobbins; Etienne Gagnon; Jernej Godec; Jason Pyrdol; Dario A A Vignali; Arlene H Sharpe; Kai W Wucherpfennig
Journal:  Sci Signal       Date:  2016-07-26       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.